Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells

Journal of Cellular Physiology

Volumn 205, Issue 2, 2005, Pages 246-252

  Secchiero, Paola ^a   Tiribelli, Mario ^b   Barbarotto, Elisa ^a   Celeghini, Claudio ^c   Michelutti, Angela ^b   Masolini, Paola ^b   Fanin, Renato ^b   Zauli, Giorgio ^c  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD5 ANTIGEN; CHIMERIC PROTEIN; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FC RECEPTOR; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; AGED; APOPTOSIS; ARTICLE; B CHRONIC LYMPHOCYTIC LEUKEMIA; B LYMPHOCYTE; BINDING AFFINITY; CELL CULTURE; CELL ISOLATION; CELL SURVIVAL; CELL VIABILITY; CHIMERA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL SURVIVAL; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 26444435775     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20392     Document Type: Article

References (23)

1. Aron JL, Parthun MR, Marcucci G, Kitada S, Mone AP, Davis ME, Shen T, Murphy T, Wickham J, Kanakry C, Lucas DM, Reed JC, Grever MR, Byrd JC. 2003. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein. Blood 102:652-658.
2. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH. 1999. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104:155-162.
3. Barragan M, Bellosillo B, Campas C, Colomer D, Pons G, Gil J. 2002. Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells. Blood 99:2969-2976.
4. Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL, Ross BD, Rehemtulla A. 2000. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci USA 97:1754-1759.
5. Dighiero G, Binet JL. 2000. When and how to treat chronic lymphocytic leukemia. N Engl J Med 343:1799-1801.
6. Ehrlich S, Infante-Duarte C, Seeger B, Zipp F. 2003. Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes. Cytokine 24:244-253.
7. Giovareili M, Musiani P, Garotta G, Ebner R, Di Carlo E, Kim Y, Cappello P, Rigamonti L, Bernabei P, Novelli F, Modesti A, Coletti A, Ferrie AK, Lollini PL, Ruben S, Salcedo T, Forni G. 1999. "Stealth Effect": Adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. J Immunol 163:4886-4893.
8. Johnston JB. 1999. Chronic lymphocytic leukemia. In: Lee GR, Lukens J, Parakevas F, Green GR, Rodgers GM, editors. Wintrobe's Clinical Hematology. Baltimore: Williams & Wilkins. pp 2405-2427.
9. Johnston JB, Kabore AF, Strutinsky J, Hu X, Paul JT, Kropp DM, Kuschak B, Begleiter A, Gibson SB. 2003. Role of the TRAIL/AP02-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia. Oncogene 22:8356-8369.
10. Jones, DT, Ganeshaguru K, Virchis AE, Folarin NI, Lowdell MW, Mehta AB, Prentice HG, Hoffbrand AV, Wickremasinghe RG. 2001. Caspase 8 activation independent of Fas (CD95/APQ-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or radiation. Blood 98:2800-2807.
11. Koyama S, Koike N, Adachi S. 2002. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: A possible mechanism of immune evasion of the tumor. J Cancer Res Clin Oncol 128:73-79.
12. LeBlanc HN, Ashkenazi A. 2003. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 10:66-75.
13. MacFarlane M, Harper N, Snowden RT, Dyer MJ, Barnett GA, Pringle JH, Cohen GM. 2002. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia. Oncogene 21:6809-6818.
14. Munzert G, Kirchner D, Stobbe H, Bergmann L, Schmid RM, Dohner H, Heimpel H. 2002. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: Analysis bf NF-kB/Rel-regulated inhibitors of apoptosis. Blood 100:3749-3756.
15. Olsson A, Diaz T, Aguilar-Santelises M, Osterborg A, Celsing F, Jondal M, Osorio LM. 2001. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D. Leukemia 15:1868-1877.
16. Pangalis GA, Vassilakopoulos TP, Dimopoulou MN, Siakantaris MP, Kontopidou FN, Angelopoulou MK. 2002. B-cronic lymphocytic leukemia: Practical aspects. Hematol Oncol 20:103-146.
17. Pedersen IM, Kitada S, Schimmer A, Kim Y, Zapata JM, Charboneau L, Rassenti L, Andreeff M, Bennett F, Sporn MB, Liotta LD, Kipps TJ, Reed JC. 2002. The triterpenoid CDDO induces apoptosis ih refractory CLL B cells. Blood 100:2965-2972.
18. Reed JC, Kitada S, Kim Y, Byrd J. 2002. Modulating apoptosis pathways in low-grade B-cell malignancies using biological response modifiers. Semin Oncol 29:10-24.
19. Ringshausen I, Schneller F, Bogner C, Hipp S, Duyster J, Peschel C, Decker T. 2002. Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: Association with protein kinase C6. Blood 100:3741-3748.
20. Secchiero P, Gonelli A, Mirandola P, Melloni E, Zamai L, Celeghini C, Milani D, Zauli G. 2002. TNF-related apoptosis-inducing ligand (TRAIL) induces monocytic maturation of both leukemic and normal myeloid precursors via a caspasedependent pathway. Blood 100:2421-2429.
21. Silvestris F, Cafforio P, Tucci M, Dammacco F. 2002. Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: A major pathogenetic mechanism of anemia in multiple myeloma. Blood 99:1305-1313.
22. Song K, Chen Y, Goke R, Wilmen A, Seidel C, Goke A, Hilliard B, Chen Y. 2000. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 191:1095-1104.
23. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH. 1999. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157-163.